{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2020:JPJYBXUKUKMNP6SWUKBIJ6OSCS","short_pith_number":"pith:JPJYBXUK","schema_version":"1.0","canonical_sha256":"4bd380de8aa298d7fa56a28284f9d214bae2d4b0b717a3da22c430621a9adea1","source":{"kind":"arxiv","id":"2005.07856","version":2},"attestation_state":"computed","paper":{"title":"Identification of Repurposable Drugs and Adverse Drug Reactions for Various Courses of COVID-19 Based on Single-Cell RNA Sequencing Data","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"q-bio.GN","authors_text":"Changlong Li, Junguk Hur, Kai Guo, Min Wu, Pan Gao, Qinqin Pu, Zhihan Wang","submitted_at":"2020-05-16T03:30:17Z","abstract_excerpt":"Coronavirus disease 2019 (COVID-19) has impacted almost every part of human life worldwide, posing a massive threat to human health. There is no specific drug for COVID-19, highlighting the urgent need for the development of effective therapeutics. To identify potentially repurposable drugs, we employed a systematic approach to mine candidates from U.S. FDA-approved drugs and preclinical small-molecule compounds by integrating the gene expression perturbation data for chemicals from the Library of Integrated Network-Based Cellular Signatures project with a publicly available single-cell RNA se"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2005.07856","kind":"arxiv","version":2},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"q-bio.GN","submitted_at":"2020-05-16T03:30:17Z","cross_cats_sorted":[],"title_canon_sha256":"0d1a2be5b7908a0959dbd558ddd5ee0eb94a1245f27475d1b100c4d9079f8a79","abstract_canon_sha256":"5274cf7f544eb8b9645a84691dbe952bacaed458aba697a87fa0ca9ff8c15c13"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T01:57:05.824440Z","signature_b64":"dmnRoSBqcyLEJ35uRYtSUq7AWLYYnTAq+mFLIM14stCXxAGeP4RnVT+yDHK3aDymJ/HZ5Q21q8+9LRLbFYA8AQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"4bd380de8aa298d7fa56a28284f9d214bae2d4b0b717a3da22c430621a9adea1","last_reissued_at":"2026-07-05T01:57:05.823969Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T01:57:05.823969Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Identification of Repurposable Drugs and Adverse Drug Reactions for Various Courses of COVID-19 Based on Single-Cell RNA Sequencing Data","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"q-bio.GN","authors_text":"Changlong Li, Junguk Hur, Kai Guo, Min Wu, Pan Gao, Qinqin Pu, Zhihan Wang","submitted_at":"2020-05-16T03:30:17Z","abstract_excerpt":"Coronavirus disease 2019 (COVID-19) has impacted almost every part of human life worldwide, posing a massive threat to human health. There is no specific drug for COVID-19, highlighting the urgent need for the development of effective therapeutics. To identify potentially repurposable drugs, we employed a systematic approach to mine candidates from U.S. FDA-approved drugs and preclinical small-molecule compounds by integrating the gene expression perturbation data for chemicals from the Library of Integrated Network-Based Cellular Signatures project with a publicly available single-cell RNA se"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2005.07856","kind":"arxiv","version":2},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2005.07856/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2005.07856","created_at":"2026-07-05T01:57:05.824027+00:00"},{"alias_kind":"arxiv_version","alias_value":"2005.07856v2","created_at":"2026-07-05T01:57:05.824027+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2005.07856","created_at":"2026-07-05T01:57:05.824027+00:00"},{"alias_kind":"pith_short_12","alias_value":"JPJYBXUKUKMN","created_at":"2026-07-05T01:57:05.824027+00:00"},{"alias_kind":"pith_short_16","alias_value":"JPJYBXUKUKMNP6SW","created_at":"2026-07-05T01:57:05.824027+00:00"},{"alias_kind":"pith_short_8","alias_value":"JPJYBXUK","created_at":"2026-07-05T01:57:05.824027+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/JPJYBXUKUKMNP6SWUKBIJ6OSCS","json":"https://pith.science/pith/JPJYBXUKUKMNP6SWUKBIJ6OSCS.json","graph_json":"https://pith.science/api/pith-number/JPJYBXUKUKMNP6SWUKBIJ6OSCS/graph.json","events_json":"https://pith.science/api/pith-number/JPJYBXUKUKMNP6SWUKBIJ6OSCS/events.json","paper":"https://pith.science/paper/JPJYBXUK"},"agent_actions":{"view_html":"https://pith.science/pith/JPJYBXUKUKMNP6SWUKBIJ6OSCS","download_json":"https://pith.science/pith/JPJYBXUKUKMNP6SWUKBIJ6OSCS.json","view_paper":"https://pith.science/paper/JPJYBXUK","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2005.07856&json=true","fetch_graph":"https://pith.science/api/pith-number/JPJYBXUKUKMNP6SWUKBIJ6OSCS/graph.json","fetch_events":"https://pith.science/api/pith-number/JPJYBXUKUKMNP6SWUKBIJ6OSCS/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/JPJYBXUKUKMNP6SWUKBIJ6OSCS/action/timestamp_anchor","attest_storage":"https://pith.science/pith/JPJYBXUKUKMNP6SWUKBIJ6OSCS/action/storage_attestation","attest_author":"https://pith.science/pith/JPJYBXUKUKMNP6SWUKBIJ6OSCS/action/author_attestation","sign_citation":"https://pith.science/pith/JPJYBXUKUKMNP6SWUKBIJ6OSCS/action/citation_signature","submit_replication":"https://pith.science/pith/JPJYBXUKUKMNP6SWUKBIJ6OSCS/action/replication_record"}},"created_at":"2026-07-05T01:57:05.824027+00:00","updated_at":"2026-07-05T01:57:05.824027+00:00"}